TAM
MDNA

Tocqueville Asset Management’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Tocqueville Asset Management’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-79,000
Closed -$23.3K – 547
2023
Q3 		$23.3K Hold
79,000
– – ﹤0.01% 509
2023
Q2 		$38.1K Hold
79,000
– – ﹤0.01% 530
2023
Q1 		$49.7K Hold
79,000
– – ﹤0.01% 522
2022
Q4 		$37.1K Sell
79,000
-38,500
-33% -$23.5K ﹤0.01% 572
2022
Q3 		$97K Buy
117,500
+4,500
+4% +$5.08K ﹤0.01% 582
2022
Q2 		$132K Buy
113,000
+25,000
+28% +$26.7K ﹤0.01% 643
2022
Q1 		$112K Hold
88,000
– – ﹤0.01% 691
2021
Q4 		$143K Sell
88,000
-5,000
-5% -$10.4K ﹤0.01% 722
2021
Q3 		$258K Sell
93,000
-4,700
-5% -$11.6K ﹤0.01% 657
2021
Q2 		$294K Buy
97,700
+5,100
+6% +$18.9K ﹤0.01% 641
2021
Q1 		$378K Hold
92,600
– – 0.01% 600
2020
Q4 		$433K Buy
92,600
+27,700
+43% +$112K 0.01% 563
2020
Q3 		$269K Buy
+64,900
New +$261K 0.01% 588

Other funds holding MDNA

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Tocqueville Asset Management's MDNA Position: Q4 2023 in Review

Tocqueville Asset Management sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2023, closing a stake of 79,000 shares — an estimated $23.3K sold.

Tocqueville Asset Management first reported a position in MDNA in Q3 2020 and held it in 13 quarters. The position peaked at $433K in Q4 2020. 3 funds tracked by Wall St. Rank hold MDNA as of Q4 2023.

  • Tocqueville Asset Management reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2023 after selling out during the quarter.
  • Tocqueville Asset Management sold 79,000 Medicenna Therapeutics Corp. Common Shares shares in Q4 2023, an estimated $23.3K.
  • Tocqueville Asset Management first reported a position in Medicenna Therapeutics Corp. Common Shares in Q3 2020 and held it in 13 quarters.
  • Tocqueville Asset Management's Medicenna Therapeutics Corp. Common Shares position peaked at $433K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2023.

Based on Tocqueville Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.